TRICITRATES ORAL SOLUTION
FDA nonproprietary name: potassium citrate, sodium citrate, and citric acid monohydrate
For 473 mL
Pharmacies pay
$14.85 filed
473 × $0.0314 per ML
CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17
Medicare Part D paid
$42.73 filed
473 × $0.09034 per ML, Part D average
Medicare's price is not your price.
Medicare Part D · DSD_PTD_RY26_P04_V10_DY24_BGM.csv · eff. 2024-01-01 to 2024-12-31 · as of 2026-06-25 · retrieved 2026-10-18
The spread
2.9× estimated
Medicare paid 2.9× what pharmacies pay.
Part D averages every strength and form sold under “Tricitrates” / “Sod/Pot/K Cit/Sod Cit/Cit Acid” into one figure, so it is not specific to this NDC.
OpenBill calculation · DSD_PTD_RY26_P04_V10_DY24_BGM.csv + nadac-national-average-drug-acquisition-cost-20261014.csv · NADAC eff. 2026-09-23 (file of 2026-10-14, retrieved 2026-10-17) · Part D 2024-01-01 to 2024-12-31 (file of 2026-06-25, retrieved 2026-10-18)
Cost-plus estimate
$22.08 estimated
$14.85 + $2.23 (15%) + $5.00 fee per fill = $22.08
This is a model, not a price any pharmacy quoted. Shipping is not included. How it is worked out
OpenBill calculation · nadac-national-average-drug-acquisition-cost-20261014.csv · NADAC eff. 2026-09-23 (file of 2026-10-14, retrieved 2026-10-17)
Open the interactive card Change the quantity, type what you were charged, and see every record in full.
What it is
TRICITRATES ORAL SOLUTION is how the CMS NADAC file names this product. The FDA NDC Directory lists it as “potassium citrate, sodium citrate, and citric acid monohydrate” and “tricitrates”, as its NDCs’ listings variously write the nonproprietary name.
FDA gives its dosage form as solution and its route as oral.
Its labelers, the companies named on the label, are PAI Holdings, LLC dba PAI Pharma and Chartwell RX, LLC.
FDA lists it under 2 Established Pharmacologic Classes: Anti-coagulant and Calculi Dissolution Agent.
The NADAC file of 2026-10-14 prices it under 2 NDCs (National Drug Codes).
NADAC classes it as a generic drug (rate-setting class G), and does not mark it as sold over the counter.
What pharmacies pay
Pharmacies pay $14.85 for 473 mL (473 × $0.0314 per ML, rounded to the cent), by the CMS NADAC file of 2026-10-14; that price took effect on 2026-09-23. That is what pharmacies pay their suppliers, not what they charge you.
NADAC’s explanation codes for it: 1, calculated from the most recently completed pharmacy survey; 5, calculated based on package size.
What NADAC measures · NADAC explanation codes
All 2 NDCs
- 00121-0677-16 · PAI Holdings, LLC dba PAI Pharma · $0.0314 per ML · eff. 2026-09-23 filed
- 62135-0438-47 · Chartwell RX, LLC · $0.0314 per ML · eff. 2026-09-23 filed
Compared with its class
The middle of its 2 NDCs’ NADAC prices is $0.0314 per ML filed.
Of the 10 other products in FDA’s Anti-coagulant class priced per ML, 9 have a higher middle NADAC price and 1 a lower one. The one in the middle is HEPARIN SOD 5,000 UNIT/ML VIAL, at $1.1796 per ML filed (eff. 2026-09-23).
Of the 21 other products in FDA’s Calculi Dissolution Agent class priced per ML, 5 have a higher middle NADAC price and 16 a lower one. The one in the middle is ANTACID ANTI-GAS LIQUID, at $0.01206 per ML filed (eff. 2026-09-23).
Prices are compared per unit, whatever the strength or dose, and a class is not a list of substitutes.
CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17
What Medicare paid
Medicare Part D paid $42.73 for 473 mL, at an average of $0.09034 per ML in 2024 (2024-01-01 to 2024-12-31) for “Tricitrates” and “Sod/Pot/K Cit/Sod Cit/Cit Acid”, every strength and form sold under that name together (Medicare Part D Spending by Drug, file of 2026-06-25).
That average covers 100 Part D claims (fills, including refills) for 2024-01-01 to 2024-12-31, across every maker, strength and form under the name.
1 of the product’s 2 NDCs have this Medicare figure; the other 1 do not, and the interactive card says why for each.
Medicare's price is not your price.
What Part D spending measures · Which Medicare figure OpenBill compares · How the spread is worked out
What to ask at the counter
None of these figures is your price: what you pay depends on your pharmacy, your insurance, coupons and discounts.
- What is your cash price for 473 mL? Is it lower than what I would pay through my insurance?
- How much is in the package I am getting? This page uses 473 mL; your package may hold a different amount.
- If you have Medicare Part D: what is my plan’s copay or coinsurance for it? The Part D average on this page is not what you pay.
- These are questions about price, not medical advice. Do not change or stop a medicine without talking to your prescriber or pharmacist.
Questions
- Why is the comparison with Medicare for TRICITRATES ORAL SOLUTION labelled estimated?
- Beyond what the card shows, the records give these reasons: The Part D figure covers 2024-01-01 to 2024-12-31; the NADAC price is from the file of 2026-10-14. Part D spending basis, as the Part D record states it: Part D 2024 average spend per dosage unit for Tricitrates / Sod/Pot/K Cit/Sod Cit/Cit Acid: all makers, strengths, forms and routes combined, claim-weighted; gross cost incl. dispensing fees and patient pay, before rebates. Unit taken as NADAC's ML. Joined on brand name.
- Why does this page start at 473 mL?
- NADAC prices this product per ML. The FDA NDC Directory’s package description gives 473 mL in one package for all 2 NDCs of this product (“473 mL in 1 BOTTLE (0121-0677-16)”), so the card starts at one package: 473 ML. Change it to match your prescription.
Related pages
Its pharmacologic classes
Related in the same class
- POTASSIUM CITRATE ER 10 MEQ TB
- CLENPIQ 175 ML SOLUTION
- SOD CITRATE-CITRIC ACID SOLN
- POTASSIUM CIT-CITRIC ACID SOLN
- PHEXXI 1.8-1-0.4% VAGINAL GEL